Who led the team that explored innovative approaches to combat Alzheimer’s disease at the Bose Institute?
Professor Anirban Bhunia
Why in the news?
“Professor Anirban Bhunia's Team at Bose Institute Unveils New Alzheimer’s Disease Research Breakthrough”
Professor Anirban Bhunia led a research team at the Bose Institute, focusing on innovative approaches to combat Alzheimer’s disease. The team specifically explored amyloid proteins, which play a central role in the development of this neurodegenerative disorder.
AMRSense, an AI-driven tool for tracking antimicrobial resistance (AMR), primarily aims to:
Which research institution led the first in-utero treatment for Spinal Muscular Atrophy (SMA)?
Which research institution led the first in-utero treatment for Spinal Muscular Atrophy (SMA)?
Which parasitic disease has Niger officially eliminated as a public health threat?
Which country has initiated the first-ever clinical trial for a vaccine targeting the Sudan species of the Ebola virus?
Consider the following statements:
Statement-I- Biolumpivaxin vaccine is expected to provide long-lasting immunity against all strains of the Lumpy Skin Disease virus.
Statement-II- Vaccines typically stimulate the immune system to produce antibodies that can neutralize the specific pathogen they are designed to target
Which one of the following is correct in respect to the above statements?
Consider the following statements:
Statement-I- Biolumpivaxin vaccine is expected to provide long-lasting immunity against all strains of the Lumpy Skin Disease virus.
Statement-II- Vaccines typically stimulate the immune system to produce antibodies that can neutralize the specific pathogen they are designed to target
Which one of the following is correct in respect to the above statements?
Consider the following statements regarding biomarkers:
1. They are exclusively used for cancer diagnosis.
2. It can be measured in various biological samples, including blood, fluids, and tissues.
3. The recent Indian research identified metabolites specific to individual cancer types, enabling highly targeted treatments.
Which of the above statements is/are correct?